SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 54 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $47,000 | -20.3% | 194,787 | +15.7% | 0.00% | – |
| Q4 2015 | $59,000 | -79.5% | 168,368 | +1.8% | 0.00% | -100.0% |
| Q3 2015 | $288,000 | -22.2% | 165,368 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $370,000 | +59.5% | 165,968 | +38.6% | 0.00% | 0.0% |
| Q1 2015 | $232,000 | -26.8% | 119,774 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $317,000 | -11.7% | 119,774 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $359,000 | -17.1% | 119,262 | +12.7% | 0.00% | 0.0% |
| Q2 2014 | $433,000 | +11.0% | 105,854 | +17.0% | 0.00% | 0.0% |
| Q1 2014 | $390,000 | -17.7% | 90,454 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $474,000 | +2.8% | 90,454 | +23.8% | 0.00% | 0.0% |
| Q3 2013 | $461,000 | +30.6% | 73,054 | +3.4% | 0.00% | 0.0% |
| Q2 2013 | $353,000 | -40.5% | 70,674 | +2.5% | 0.00% | -50.0% |
| Q1 2013 | $593,000 | – | 68,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
| Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
| CAXTON CORP | 57,000 | $99,000 | 0.13% |
| Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
| TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
| Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
| LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
| Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |